AUTL · Autolus Therapeutics plc American Depositary Share
View on chartInsiders & Stakes
| Piccina Cintia U.S. CCO & Country Gen Manager | ▼ Sell | Open Market | 13,287 Shares held | 9/2/2026 | View profile |
Transaction History
| Piccina Cintia | ▼ Sell | Open Market | 6,713 | $16K | 9/2/2026 |
| Piccina Cintia | ▲ Buy | Option Exercise | 20,000 | $47K | 9/1/2026 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Autolus Therapeutics to Present Data at Rheumatology Conference
Autolus Therapeutics announced that an abstract has been filed for presentation at the American College of Rheumatology Convergence 2026. This event serves as a key venue for sharing clinical updates in the rheumatology field. The news provides a specific upcoming date for stakeholders to monitor potential data releases related to the company's pipeline.
Autolus Therapeutics to Present Data at Rheumatology Conference. Autolus Therapeutics announced that an abstract has been filed for presentation at the American College of Rheumatology Convergence 2026. This event serves as a key venue for sharing clinical updates in the rheumatology field. The news provides a specific upcoming date for stakeholders to monitor potential data releases related to the company's pipeline.